Table 1 Characteristics of patients and controls
From: Impaired skin microcirculation in paediatric patients with type 1 diabetes mellitus
Patient | Controls | p | |
|---|---|---|---|
n | 68 (33 m/35f) | 102 (48 m/54f) | |
Age [year] | 12.93 ± 3.34 | 12.84 ± 3.30 | 0.963 |
13.4 (6.3-19) | 13.2 (6.4-19) | ||
Height | |||
Absolute [cm] | 157 ± 18.8 | 158 ± 18.4 | 0.720 |
159 (111–195) | 162 (116–191) | ||
SDS | 0.04 (−2.65-2.7) | 0.37 (−2.03-2.10) | 0.076 |
Weight | |||
Absolute [kg] | 50.9 ± 16.3 | 48.0 ± 17.0 | 0.190 |
52.6 (21.0-95.0) | 48.5 (18.0-92.0) | ||
SDS | 0.49 (−2.91-13.7) | 0.17 (−0.15-3.84) | 0.080 |
BMI | |||
Absolute [kg/m2] | 19.7 (14.0-39.3) | 18.2 (12.5-28.1) | 0.008 |
SDS | 0.23 (−2.74-3.92) | −0.23 (−3.20-2.51) | 0.002 |
Systolic blood pressure | |||
Absolute [mm Hg] | 117.1 ± 13.0 | 110.0 ± 11.1 | <0.001 |
117 (80–147) | 110 (89–165) | ||
SDS | 0.91 (−2035-2.94) | 0.05 (−2.44-1.58) | <0.001 |
Diastolic blood pressure | |||
Absolute [mm Hg] | 71.1 ± 9.4 | 65.6 ± 10.1 | <0.001 |
72 (39–94) | 65.0 (40–105) | ||
SDS | 0.65 (−1.65-2.35) | −0.26 (−3.23-2.0) | <0.001 |
cIMT [SDS] | −0.19 (3.9-3.0) | −0.31 (−2.8-1.9) | 0.328 |
Duration of disease [year] | 5.0 ± 3.97 | ||
4.1 (1.0-16.0) | |||
Blood glucose [mmol/l] | 9.29 ± 4.95 | ||
8.60 (1.60-20.9) | |||
Total cholesterol [mmol/l] | 4.61 ± 0.88 | ||
4.60 (2.6-7.3) | |||
LDL-cholesterol [mmol/l] | 2.63 ± 0.73 | ||
2.66 (0.89-5.10) | |||
HDI-cholesterol [mmol/l] | 1.54 ± 0.39 | ||
1.51 (0.91-2.58) | |||
Triglycerides [mmol/l] | 1.80 ± 0.70 | ||
1.60 (0.60-3.66) | |||
Mean daily Insulin dosage [IU/kg] | 093 (024–2.22) | ||
Actual HbA1c [%] | 8.65 ± 1.8 | 5.37 ± 0.22 | <0.001 |
8.3 (6.0-14.5) | 5.4 (4.9-6.0) | ||
Mean Hba1c [%] | 8.62 ± 1.2 | ||
8.4 (6.6-11.7) | |||